Apricus Biosciences to acquire PediatRx - MarketLine Financial Deals

Apricus Biosciences to acquire PediatRx

Apricus Biosciences to acquire PediatRx - MarketLine Financial Deals
Apricus Biosciences to acquire PediatRx
Published Jan 27, 2012
3 pages — Published Jan 27, 2012
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Apricus Biosciences, Inc., a specialty pharmaceutical company, has signed a non-binding term sheet with PediatRx, Inc. under which Apricus may acquire PediatRx through a merger.

  
Source:
Document ID
MA96893_120201
Country
Country
Ticker
APRI=US
Ticker
SKRY=CA
Ticker
PEDX=US
Company
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Apricus Biosciences to acquire PediatRx" Jan 27, 2012. Alacra Store. Dec 04, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Apricus-Biosciences-to-acquire-PediatRx-2052-76848>
  
APA:
MarketLine Financial Deals. (2012). Apricus Biosciences to acquire PediatRx Jan 27, 2012. New York, NY: Alacra Store. Retrieved Dec 04, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Apricus-Biosciences-to-acquire-PediatRx-2052-76848>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.